跳至主要内容
临床试验/CTRI/2023/03/050887
CTRI/2023/03/050887已完成4 期

Dermatological safety evaluation of test products by Primary Irritation Patch Test within 24 hours of apply on healthy human all skin types

Dabur India Limited0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Voluntary men and women ratio of 1:1 between 18 and 65 years.
  • 2.Having healthy skin on test area as assessed by dermatological examination.
  • 3.For whom the investigator considers that the compliance will be correct.
  • 4.Subjects with normal, dry, oily and combination skin
  • 5.Subjects cooperating informed of the need and duration of the examination and ready to comply
  • with protocol procedures.

排除标准

  • 1.Pregnant/nursing mothers.
  • 2.Scars, excessive terminal hair, or tattoo on the studied area.
  • 3.Dermatological infection/pathology on level of studied area.
  • 4.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material)

研究者

相似试验